Compositions containing and methods of using 1-aminoindan and de

Details Compositions containing and methods of using 1-aminoindan and de Compositions containing and methods of using 1-aminoindan and de

1997-10-09

1999-03-09

Lambkin, Deborah C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514617, A61K 31165, A61K 3116

Patent

active

058801596

ABSTRACT:
Novel derivatives of 1-aminoindan and their salts are described. Optically active 1-aminoindan derivatives are prepared by reacting a N-benzyl analog of the desired compound with an enantiomer of mandelic acid. Parkinson's disease, dementia, epilepsy, convulsions, or seizures are treated by administering a compound of the formula: ##STR1##

REFERENCES:
patent: 2573645 (1951-10-01), Kerwin et al.
patent: 2916490 (1959-12-01), Schenk et al.
patent: 2982783 (1961-05-01), Schenk et al.
patent: 3060091 (1962-10-01), Witkin et al.
patent: 3123642 (1964-03-01), Temple et al.
patent: 3178478 (1965-04-01), Huebner
patent: 3201470 (1965-08-01), Huebner
patent: 3253037 (1966-05-01), Huebner
patent: 3308157 (1967-03-01), Robertson et al.
patent: 3637740 (1972-01-01), Sarges
patent: 3704323 (1972-11-01), Krapcho
patent: 3709996 (1973-01-01), Gittos et al.
patent: 3751420 (1973-08-01), Hauck et al.
patent: 3991207 (1976-11-01), Sarges et al.
patent: 4096173 (1978-06-01), Molloy
patent: 4128666 (1978-12-01), Bondinell et al.
patent: 4132737 (1979-01-01), Molloy
patent: 4134997 (1979-01-01), Cannon et al.
patent: 4172093 (1979-10-01), Goransson-Dahlander et al.
patent: 4632939 (1986-12-01), Beedle et al.
patent: 4788130 (1988-11-01), Oshiro et al.
patent: 4833273 (1989-05-01), Goel
patent: 4873241 (1989-10-01), Napier et al.
patent: 5071875 (1991-12-01), Horn et al.
patent: 5118704 (1992-06-01), Minaskanian et al.
patent: 5153225 (1992-10-01), Schohe et al.
patent: 5225596 (1993-07-01), Carlsson et al.
patent: 5286747 (1994-02-01), Arvidsson et al.
patent: 5389687 (1995-02-01), Schaus et al.
patent: 5569669 (1996-10-01), Guillaument et al.
patent: 5646188 (1997-07-01), Gilad et al.
Horn et al, "Steric Requirements for Catecholamine up-take by Rat Brain Synaptosomes: Studies with Rigid Analogs of Amphetamine", J. Pharm. Exp. Ther., vol. 180, pp. 523-530, 1972.
Oshiro, et al., "Novel Cerebroprotective Agents with Central Nervous System Stimulating Activity. 1. Synthesis and Pharmacology of 1-Amino-7-hydroxyindan Derivatives" J. Med. Chem. (1991) 34(7): 2004-2013.
Martin et al. (II), (1974) Discriminant Analysis of the Relationship Between Physical Properties and the Inhibition of Monoamine Oxidase by Aminoindans, J. Med. Chem., (17)4:409-413.
J. Pharm. Exp. Ther., 180:523-530, 1975.
Martin et al., (1974) Potential Anti-Parkinson Drugs Designed by Receptor Mapping, Chem. Abs., 78:119099.
Horn et al., (1972) Steric Requirements for Catecholamine Up-take by Rat Brain Synapsomes Studies with Rigid Analogs of Amphetamine, J. Pharm. Exp. Ther., 180:523-530.
Martin et al., (1973) Potential anti-Parkinson Drugs by Receptor Mapping, CA78:119099, J. Med. Chem., (16)2:147-150.
Merck Manual, 15th Edition, (1987) 1030-1033.

Affiliated with

Also associated with

Rating

Compositions containing and methods of using 1-aminoindan and de does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions containing and methods of using 1-aminoindan and de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing and methods of using 1-aminoindan and de will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1321589